Efficacy and safety of tofacitinib in patients with ulcerative colitis a prospective national multicenter cohort

Brief description of study

The purpose of this research study is to evaluate the effectiveness and safety of Tofacitinib in patients with ulcerative colitis who are taking it in a standard of care setting. Tofacitinib is an FDA approved drug for the treatment of ulcerative colitis.


Clinical Study Identifier: s19-00191
Principal Investigator: David P Hudesman.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.